Clover Health Investments (CLOV) Shares Outstanding (2019 - 2026)

Clover Health Investments has reported Shares Outstanding for 8 years, with the latest figure at $429.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3.72% year-over-year to $429.6 million; the trailing twelve-month figure through Mar 2026 stood at $429.6 million (up 3.72% YoY), and the FY2025 full-year result was $92.4 million, down 77.71% from the prior year.
• Shares Outstanding for Q1 2026 stood at $429.6 million, up from $92.4 million in the prior quarter.
• The five-year high for Shares Outstanding was $426.7 million in Q4 2025, with the low at $87.9 million in Q2 2023.
• Historically, Shares Outstanding has averaged $330.7 million across 5 years, with a median of $399.4 million in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding plunged 81.3% — and 2025, when it jumped 373.78%.
• Clover Health Investments' Shares Outstanding stood at $384.0 million in 2022, then climbed by 4.48% to $401.2 million in 2023, then increased by 3.32% to $414.5 million in 2024, then sank by 77.71% to $92.4 million in 2025, then soared by 365.02% to $429.6 million in 2026.
• The last three Shares Outstanding figures came in at $429.6 million (Q1 2026), $92.4 million (Q4 2025), and $421.8 million (Q3 2025), per Business Quant data.